Breast Density, Elevated Breast Cancer Risk Highest in Hispanic Women

TON - March 2017, Vol 10, No 2 - Breast Cancer
Meg Barbor, MPH

Cape Town, South Africa—Breast density, which can affect the visualization of mammography, is one of the strongest and most consistent risk factors for breast cancer. Women with the highest mammographic density (≥75%) are at a 4- to 6-fold increased risk for developing breast cancer compared with women with the least dense tissue.

Although an estimated 50% of women in the United States have dense breasts, data on ethnic variations in breast density and breast cancer risk are limited. Research on this topic has seldom included minorities, such as black and Hispanic women, according to a group of researchers at Georgetown University in Washington, DC.

The team, led by Bridget Oppong, MD, Assistant Professor of Surgery, Division of Breast Surgery, Georgetown University Hospital of Surgery, Washington, DC, conducted an investigation into the differences in breast cancer risk among varying ethnic populations and presented the results in a poster at the American Association for Cancer Research International Conference on New Frontiers in Cancer Research.

The researchers reviewed breast density recorded at initial mammographic screening in women who presented to the Capital Breast Care Center and Georgetown University Hospital from 2010 to 2014. From imaging reports, they recorded the American College of Radiology BI-RADS density categories; 1, fatty; 2, scattered fibroglandular densities; 3, heterogeneously dense; and 4, extremely dense.

From 2010 to 2014, mammographic density was recorded for 2147 women: 940 (43.8%) black, 893 (41.6%) Hispanic, and 314 (14.6%) white. The investigators observed high breast density (categories 3 and 4) in Hispanic, premenopausal, nonobese women without children (P <.001), and found that these characteristics were predictive of high mammographic density. Obese women were 70% less likely to have high breast density than nonobese women.

In this analysis, Hispanic women were found to have the highest breast density, followed by black women, with white women having the lowest. The breast density and cancer interplay may be a crucial element in addressing racial and ethnic disparities in breast cancer outcomes, but further investigation of the impact of obesity on breast density in the understudied Hispanic population is needed.

“As there is a paucity of reporting on mammographic density in minority women, these data presented are valuable, especially as we are able to have a comparison group of whites,” the researchers noted.

Related Items
Preserving Sexual Function in Women After Cancer Treatment
Meg Barbor, MPH
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in ONS
MONALEESA-7 Sets New Standard of Care for Premenopausal Women with Advanced Breast Cancer
Phoebe Starr
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in Breast Cancer
What to Expect with USP 800: Implementing Safe Handling Practices of Hazardous Drugs
Meg Barbor, MPH
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in ONS
Creating a Compassionate Workplace: Promoting Civility in Oncology Nursing
Meg Barbor, MPH
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in ONS
Assessing the Value of Digital Health Technology in Cancer Care
Meg Barbor, MPH
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in ACCC
The Evolving Role of Precision Medicine in Clinical Practice
Meg Barbor, MPH
TOP - August 2019, Vol 12, No 3 published on July 29, 2019 in HOPA
Talzenna (Talazoparib) New PARP Inhibitor Approved for the Treatment of HER2-Negative Advanced Breast Cancer with Germline BRCA Mutation
Lisa A. Raedler, PhD, RPh, Medical Writer
2019 Fourth Annual Oncology Guide to New FDA Approvals published on June 5, 2019 in Breast Cancer, Drug Updates, FDA Approvals
FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer
Yvette Florio Lane
Web Exclusives published on May 14, 2019 in Breast Cancer, FDA Approvals, In the News
New HOPA Committee Aims to Improve Patient Outreach Services
Meg Barbor, MPH
TOP - May 2019, Vol 12, No 2 published on May 13, 2019 in HOPA
T-DM1 Reduces Residual Invasive Disease in Patients with HER2-Positive Breast Cancer After Chemotherapy
Phoebe Starr
TOP - May 2019, Vol 12, No 2 published on May 13, 2019 in Breast Cancer
Last modified: March 7, 2017